KYTXKyverna Therapeutics, Inc.

Healthcare
$6.18+14% 1Y

The financials

Kyverna Therapeutics, Inc. by the numbers

The next results filing is expected around Nov 11, 2026, the same week as a year ago.

Kyverna Therapeutics, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$40M−$44Mn/a
Net income−$38M−$42Mn/a
Diluted EPS−$0.63−$0.97n/a

Biotechnology

The closest names by size in the same industry

Compare peers
FENC+2.9%
FENNEC PHARMACEUTICALS INC.
IRD+0.68%
Opus Genetics, Inc.
ARCT+0.71%
Arcturus Therapeutics Holdings Inc.
CBIO+4.4%
CRESCENT BIOPHARMA, INC.
ZURA-1.4%
Zura Bio Ltd
ENTA-2.2%
ENANTA PHARMACEUTICALS INC